Researchers at the Salk Institute for Biological Studies in California have shown that a single injection of a protein called Fibroblast Growth Factor (FGF1) is enough to restore blood sugar levels to a healthy range for more than two days in mice with diet -induced diabetes (the same as Type 2 Diabetes
Mellitus in humans). The research is in its early stages so how this happens is still not known but scientists know that it works in a similar way to the existing diabetes
drugs- glitazones by making cells more sensitive to insulin and thereby reducing blood glucose levels.
Glitazones can have side effects such as weight gain or heart problems in humans but this is not the case with FGF1. Researchers found that FGF1 did not set off these side effects or cause glucose levels to drop to very low levels, a risk factor associated with many glucose-lowering agents. Instead, the injections restored the body’s own ability to naturally regulate insulin and blood sugar levels, keeping glucose amounts within a safe range.
Once perfected, it can become a very safe and effective alternative to controlling diabetes.
Diabetes Update – Autumn 2014